跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 29,538 条关于
“Mucopolysaccharidosis I”
全部
29,538
临床试验
22,626
药物
618
机构
97
资讯
6,197
2年前
JCR Pharmaceuticals' JR-441 Receives Clearance for Phase I MPS IIIA Trial in Japan
7年前
Denali's Hunter Syndrome Candidate Receives FDA Orphan Drug and Rare Pediatric Disease Designations
去年
GC Biopharma's Hunterase ICV Approved in Russia for Severe Hunter Syndrome
去年
CDSCO Panel Approves Label Updates for Sanofi's Rare Disease Therapies Fabrazyme and Aldurazyme
去年
FDA Grants Orphan Drug Designation to JR-446 for Rare Neurological Disorder MPS IIIB
去年
Immusoft's Engineered B Cell Therapy Shows Promise in Phase 1 MPS I Trial
3年前
Ultragenyx's UX111 Gene Therapy Shows Sustained Efficacy in MPS IIIA Patients
去年
REGENXBIO and Nippon Shinyaku Partner to Advance Gene Therapies for MPS I and MPS II
9个月前
Immusoft Receives FDA Orphan Drug Designation for Engineered B Cell Therapy ISP-002 in Hunter Syndrome
去年
Immusoft Reports Breakthrough Results from First-Ever Engineered B Cell Therapy in MPS I Clinical Trial
第 1 页,共 620 页
上一页
下一页